A Real World Report on Intravenous High-Dose and Non-High-Dose Proton-Pump Inhibitors Therapy in Patients with Endoscopically Treated High-Risk Peptic Ulcer Bleeding

Background and Study Aims. The optimal dose of intravenous proton-pump inhibitor (PPI) therapy for the prevention of peptic ulcer (PU) rebleeding remains controversial. This study aimed to understand the real world experiences in prescribing high-dose PPI and non-high-dose PPI for preventing rebleed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Lung-Sheng, Lin, Sheng-Chieh, Kuo, Chung-Mou, Tai, Wei-Chen, Tseng, Po-Lin, Chang, Kuo-Chin, Kuo, Chung-Huang, Chuah, Seng-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403596/
https://www.ncbi.nlm.nih.gov/pubmed/22844276
http://dx.doi.org/10.1155/2012/858612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403596/
https://www.ncbi.nlm.nih.gov/pubmed/22844276
http://dx.doi.org/10.1155/2012/858612

Ejemplares similares